Cargando…

181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL

BACKGROUND AND AIMS: Patient's health/medical literacy may affect the healthcare promotion. There are various educational models for patient. The physician prescribed information intervention seems to be effective and demanded way of patient information delivery. We presented physician prescrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavgani, Vahideh Zarea, Golmohammadi, Ali, Sadeghi-Bazargani, Homayoun, Majd, Faranak Kazemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759380/
http://dx.doi.org/10.1136/bmjopen-2016-015415.181
_version_ 1783291185071128576
author Gavgani, Vahideh Zarea
Golmohammadi, Ali
Sadeghi-Bazargani, Homayoun
Majd, Faranak Kazemi
author_facet Gavgani, Vahideh Zarea
Golmohammadi, Ali
Sadeghi-Bazargani, Homayoun
Majd, Faranak Kazemi
author_sort Gavgani, Vahideh Zarea
collection PubMed
description BACKGROUND AND AIMS: Patient's health/medical literacy may affect the healthcare promotion. There are various educational models for patient. The physician prescribed information intervention seems to be effective and demanded way of patient information delivery. We presented physician prescribed, medical librarian provided information after the physician confirmation to HF patients classified in functional class III or IV. The purpose of this study was to determine whether physician prescribed information intervention would decrease the rate of hospital re-admission in heart failure patients with functional class III or IV. The secondary outcomes were the cost of re-admission and change in number and type of medication prescription (Rx). METHODS: We performed a 12-month randomized controlled trial from December 2013 to December 2014. 120 Patients were randomly allocated into two groups of intervention (n=60) and control (n=60). The control group received routine information given by nurse or physician and the intervention group received routine information plus Information Prescription (IP) prescribed by physician and presented to patient by librarian who explain patient how to use the prescription and describe it orally. Data were collected by telephone interviews with the follow up interval of 3, 6 and 12 months after discharge. Analysis of data was performed continually. Primary outcome was re-admission and or death in HF patients. RESULTS: Patients were included with mean age 71.05±11.3. Patients in the intervention group had a lower rate of hospital re-admission or death upon adjusting a Cox survival model, the patients in the intervention group compared to control group [RR: 0.57 CI: 0.4–0.81] NNT: 3.3, CI NNT: 7.7–2.13. Fewer patients died during one year in intervention group compared to the control group (7vs15) [P=0.059, RR=0.47, CI: 0.20–1.06] NNT: 7.69 CI NNT: 3.7–333. There was no significant difference in medication changes in intervention group compared to control group [RR=5; 95%CI: 2.6–9.8] NNT: 1.87 CI NNT: –1.47––2.76. Financial study demonstrated nearly triple difference in intervention and control per patient re-admission cost. CONCLUSION: Findings of this pilot study have shown that physician prescribed information intervention is clinically effective in reduction of death and re-admission rate in HF patients classified in functional class of III or IV. However to achieve the level of certainty based on statistical significance more evidence are still needed. Physician prescribed information intervention is a low cost, safe and risk free intervention comparing to other complementary intervention specially other educational programs for chronic conditions such as HF.
format Online
Article
Text
id pubmed-5759380
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57593802018-02-12 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL Gavgani, Vahideh Zarea Golmohammadi, Ali Sadeghi-Bazargani, Homayoun Majd, Faranak Kazemi BMJ Open Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira BACKGROUND AND AIMS: Patient's health/medical literacy may affect the healthcare promotion. There are various educational models for patient. The physician prescribed information intervention seems to be effective and demanded way of patient information delivery. We presented physician prescribed, medical librarian provided information after the physician confirmation to HF patients classified in functional class III or IV. The purpose of this study was to determine whether physician prescribed information intervention would decrease the rate of hospital re-admission in heart failure patients with functional class III or IV. The secondary outcomes were the cost of re-admission and change in number and type of medication prescription (Rx). METHODS: We performed a 12-month randomized controlled trial from December 2013 to December 2014. 120 Patients were randomly allocated into two groups of intervention (n=60) and control (n=60). The control group received routine information given by nurse or physician and the intervention group received routine information plus Information Prescription (IP) prescribed by physician and presented to patient by librarian who explain patient how to use the prescription and describe it orally. Data were collected by telephone interviews with the follow up interval of 3, 6 and 12 months after discharge. Analysis of data was performed continually. Primary outcome was re-admission and or death in HF patients. RESULTS: Patients were included with mean age 71.05±11.3. Patients in the intervention group had a lower rate of hospital re-admission or death upon adjusting a Cox survival model, the patients in the intervention group compared to control group [RR: 0.57 CI: 0.4–0.81] NNT: 3.3, CI NNT: 7.7–2.13. Fewer patients died during one year in intervention group compared to the control group (7vs15) [P=0.059, RR=0.47, CI: 0.20–1.06] NNT: 7.69 CI NNT: 3.7–333. There was no significant difference in medication changes in intervention group compared to control group [RR=5; 95%CI: 2.6–9.8] NNT: 1.87 CI NNT: –1.47––2.76. Financial study demonstrated nearly triple difference in intervention and control per patient re-admission cost. CONCLUSION: Findings of this pilot study have shown that physician prescribed information intervention is clinically effective in reduction of death and re-admission rate in HF patients classified in functional class of III or IV. However to achieve the level of certainty based on statistical significance more evidence are still needed. Physician prescribed information intervention is a low cost, safe and risk free intervention comparing to other complementary intervention specially other educational programs for chronic conditions such as HF. BMJ Publishing Group 2017-02-08 /pmc/articles/PMC5759380/ http://dx.doi.org/10.1136/bmjopen-2016-015415.181 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
Gavgani, Vahideh Zarea
Golmohammadi, Ali
Sadeghi-Bazargani, Homayoun
Majd, Faranak Kazemi
181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title_full 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title_fullStr 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title_full_unstemmed 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title_short 181: INFORMATION PRESCRIPTION FOR HEART FAILURE PATIENTS; A RANDOMIZED CONTROLLED TRIAL
title_sort 181: information prescription for heart failure patients; a randomized controlled trial
topic Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759380/
http://dx.doi.org/10.1136/bmjopen-2016-015415.181
work_keys_str_mv AT gavganivahidehzarea 181informationprescriptionforheartfailurepatientsarandomizedcontrolledtrial
AT golmohammadiali 181informationprescriptionforheartfailurepatientsarandomizedcontrolledtrial
AT sadeghibazarganihomayoun 181informationprescriptionforheartfailurepatientsarandomizedcontrolledtrial
AT majdfaranakkazemi 181informationprescriptionforheartfailurepatientsarandomizedcontrolledtrial